Opko Health OPK
NASDAQ OPK
$1.74 +0.04 (+2.66%)
As of: Sep 22, 2026 · 10:06 AM EDT

Opko Health (OPK) Equity Income (2012 - 2026)

Opko Health's (OPK) quarterly Equity Income came in at -$2000.0 in Q1 2026, up 77.78% on a YoY basis from -$1125.0 in Q1 2025, and up 88.24% quarter-over-quarter from -$17000.0 in Q4 2025.

Analysis

Opko Health (OPK) Equity Income (2012 - 2026) Analysis & Trends

Opko Health (OPK) has reported Equity Income for 15 consecutive years, with -$2000.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Equity Income rose 77.78% year-over-year to -$2000.0; the trailing twelve-month figure through Jun 2026 stood at -$22000.0 (down 15.79% YoY), and the FY2025 full-year result was -$29000.0, down 61.11% from the prior year.
  • Equity Income improved to -$2000.0 in Q1 2026 per OPK's latest filing, from -$17000.0 in the prior quarter.
  • Across five years, Equity Income topped out at -$2000.0 in Q1 2026 and bottomed at -$268000.0 in Q2 2022.
  • Historically, Equity Income has averaged -$35666.7 across 5 years, with a median of -$17000.0 in 2025.
  • The widest YoY moves for Equity Income: up 94.85% in 2022, down 300.0% in 2022.
  • Over 5 years, Equity Income stood at -$24000.0 in 2022, then surged by 66.67% to -$8000.0 in 2023, then gained by 12.5% to -$7000.0 in 2024, then tumbled by 142.86% to -$17000.0 in 2025, then soared by 88.24% to -$2000.0 in 2026.
  • According to Business Quant data, Equity Income over the past three periods registered -$2000.0, -$17000.0, and -$3000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -2.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -10.46 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,000.00
Dec 31, 2025 -17,000.00
Sep 30, 2025 -3,000.00
Mar 31, 2025 -9,000.00
Sep 30, 2024 -7,000.00
Jun 30, 2024 -3,000.00
Mar 31, 2024 -3,000.00
Dec 31, 2023 -8,000.00
Sep 30, 2023 -20,000.00
Jun 30, 2023 -42,000.00
Mar 31, 2023 -37,000.00
Dec 31, 2022 -24,000.00
Sep 30, 2022 -43,000.00
Jun 30, 2022 -268,000.00
Mar 31, 2022 -49,000.00
Dec 31, 2021 -466,000.00
Sep 30, 2021 -53,000.00
Jun 30, 2021 -67,000.00
Mar 31, 2021 -43,000.00
Dec 31, 2020 -47,000.00
API Access

Opko Health Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=OPK&period=max&api_key=YOUR_API_KEY